Study of chronic lymphocytic leukemia cells by FT-IR spectroscopy and cluster analysis

Leukemia Research

Volumn 20, Issue 8, 1996, Pages 649-655

  Schultz, Christian P ^a   Liu, Kan Zhi ^a   Johnston, James B ^b   Mantsch, Henry H ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chronic lymphocytic leukemia; Cluster analysis; FT IR spectroscopy

Indexed keywords

DNA; LIPID; PROTEIN;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA CONTENT; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LEUKEMIA CELL; LIPID ANALYSIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0030221522     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00019-7     Document Type: Article

References (32)

1. 1. O'Brien S., Giglio A. del & Keating M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85, 307.
2. 2. Juliusson G. & Gahrton G. (1993) Chromosomal abnormalities in B-cell chronic lymphocytic leukemia. In Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments (Cheson B.D., Ed.), p. 83. Marcel Dekker, New York.
3. 3. Schena M., Larsson L.-G., Gottardi D., Gaidano G., Carlsson M., Nilsson K. & Caligaris-Cappio F. (1992) Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79, 2981.
4. 4. Hanada M., Delia D., Aiello A., Stadtmauer E. & Reed J. C. (1993) Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820.
5. 5. Aman P., Gordon J., Mellstedt H., Biberfeld P. & Klein G. (1988) Buoyant density characterization of neoplastic cell populations in patients with chronic B-lymphocytic leukemia. Eur. J. Haematol. 40, 142.
6. 6. Greg E., Hamblin T., Smith J. & Stevenson F. (1988) Heterogeneity in neoplastic cell populations in chronic lymphocytic leukemia defined by immunglobulin expression and secretion in vitro. Leukemia Res. 12, 123.
7. 7. Mantsch H. H. & McElhaney R. N. (1991) Phospholipid phase transitions in model and biological membranes as studied by infrared spectroscopy. Chem. Phys. Lipids 57, 213.
8. 8. Surewicz W. K. & Mantsch H. H. (1988) New insight into protein secondary structure from resolution enhanced infrared spectra. Biochim. Biophys. Acta 952, 115.
9. 9. Taillandier E. & Liquier F. (1992) Infrared spectroscopy of DNA. Meth. Enzymol 211, 307.
10. 10. Rigas B., Morgallo S., Goldman I. S. & Wong P. T. T. (1990) Human colorectal cancers display abnormal Fourier transform infrared spectra. Proc. Natl Acad. Sci. 87, 8140.
11. 11. Choo L. P., Jackson M., Halliday W. C. & Mantsch H. H. (1993) Infrared spectroscopic characterisation of multiple sclerosis plaques in the human central nervous system. Biochim. Biophys. Acta 1182, 333.
12. 12. Fabian H., Choo L. P., Szendrei G. I., Jackson M., Halliday W. C., Otvos L. & Mantsch H. H. (1993) Infrared spectroscopic characterisation of Alzheimer plaques. Appl. Spectrosc. 47, 1513.
13. 13. Wong P. T. T., Goldstein S. M., Grekin R. C., Godwin T. A., Pivik C. & Rigas B. (1993) Distinct infrared spectroscopic patterns of human basal cell carcinoma of the skin. Cancer Res. 53, 762.
14. 14. Eysel H. H., Jackson M., Mantsch H. H. & Thomson G. T. D. (1993) Carbon dioxide clathrates: an IR spectroscopic marker for arthritis? Appl. Spectrosc. 47, 1519.
15. 15. Shaw R. A., Kotowich S., Mantsch H. H. & Leroux M. (1996) Quantitation of protein, creatinine, and urea in urine by near-infrared spectroscopy. Clin. Biochem. 29, 11.
16. 16. Fabian H., Jackson M., Murphy L., Watson P. H., Fichtner I. & Mantsch H. H. (1995) A comparative infrared spectroscopic study of human breast tumours and breast tumour cell xenografts. Biospectroscopy 1, 37.
17. 17. Polli E. & Semenza G. (1955) Deoxyribonucleic acids from normal and leukaemic human leucocyte. R.C. Inst. Lomb. Sci. Lett. (Rend. Sci.) 89, 160.
18. 18. Benedetti E., Papineschi F., Vergamini P., Consolini R. & Spremolla G. (1984) Analytical infrared spectral differences between human normal and leukaemic cells (CLL) - I. Leukemia Res. 8, 483.
19. 19. Benedetti E., Palatresi M. P., Vergamini P., Papineschi F. & Spremolla G. (1985) New possibilities of research in chronic lymphatic leukemia by means of Fourier transform-infrared spectroscopy - II. Leukemia Res. 9, 1001.
20. 20. Spremolla G., Benedetti E., Vergamini P., Andreucci M. C. & Macchia P. (1988) An investigation of acute lymphoblastic leukemia (ALL) in children by means of infrared spectroscopy. Part IV. Haematologica 73, 21.
21. 21. Benedetti E., Palatresi M. P., Vergamini P., Papineschi F., Andreucci M. C. & Spremolla G. (1986) Infrared characterization of nuclei isolated from normal and leukemic (B-CLL) lymphocytes: Part III. Appl. Spectrosc. 40, 39.
22. 22. Johnston J. B., Verburg L., Shore T., Williams M., Israels L. G. & Begleiter A. (1994) Combination therapy with nucleoside analogs and alkylating agents. Leukemia 8, Suppl, 140.
23. 23. Naumann D., Helm D. & Labischinski H. (1991) Microbiological characterizations by FT-IR spectroscopy. Nature 351, 81.
24. 24. Wong P. T. T., Papavassiliou E. D. & Rigas B. (1991) Phosphodiester stretching bands in infrared spectra of human tissues and cultured cells. Appl. Spectrosc. 45, 1563.
25. 25. Mantsch H. H. & Jackson M. (1995) Molecular spectroscopy in biodiagnostics (from Hippocrates to Herschel and beyond). J. Mol. Struct. 347, 187.
26. 26. Benedetti E., Teodori L., Trinca M. L., Vergamini P., Salvati F., Mauro F. & Spremolla G. (1990) A new approach to the study of human solid tumor cells by means of FT-IR microspectroscopy. Appl. Spectrosc. 44, 1276.
27. 27. Juliusson G., Oscier D. G., Fitchett M., Ross F. M., Stockdill G., Mackie M. J., Parker A. C., Castoldi G. L., Cuneo A., Knuutila S., Elonen E. & Gahrton G. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosome abnormalities. New Engl. J. Med. 323, 720.
28. 28. Kay N. E., Ranhei E. A. & Peterson L. C. (1995) Tumor suppressor genes and clonal evolution in B-CLL. Leuk. Lymph. 18, 41.
29. 29. Peterson L. C., Lindquist L. L., Church S. & Kay N. E. (1992) Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwest patients. Genes Chromosom. Cancer 4, 273.
30. 30. Dohner H., Fischer K., Bentz M., Hansen K., Benner A., Cabot G., Diehl D., Schlenk R., Coy J., Stilgenbauer S., Volkmann M., Galle P. R., Poustka A., Hunstein W. & Lichter P. (1995) p53 gene deletion predicts for poor survival and non-response therapy with purine analogs in chronic B-cell leukemias. Blood 85, 1580.
31. 31. Stilgenbauer S., Dohner H., Bulgay-Morschel M., Weitz S., Bentz M. & Lieter P. (1993) High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukemia related by interphase cytogenetics. Blood 81, 2118.
32. 32. Watanabe T., Hotta T., Ichikawa A., Kinoshita T., Hirokazu N., Uchida T., Murate T. & Saito H. (1994) The mdm-2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 84, 3158.